Skip to Page Content
Top Groups:
hostvouchet
Shopping
General
International News
US Business
Leisure Lifestyles
Social Networking
Bookmarking
(more ยป)
Post Details
-
Phase 1 Clinical Trial Of FG-3019, Anti-Connective Tissue Growth Factor (CTGF) Investigational Therapy, In Patients With Pancreatic Cancer Launched
FibroGen, Inc. has announced that an open-label, phase 1 clinical trial designed to evaluate the safety and tolerability of FG-3019, a fully human monoclonal antibody against connective tissue growth factor (CTGF), in combination with gemcitabine and...
- Saved By: healthmaster01
- Tags: cancer , of , phase , trial , growth , therapy , in , with , 1 , patients , tissue , clinical , launched , factor , pancreatic , fg 3019 , anti connective , ctgf , and investigational
- Group: (none)
post comments
[Add Comment]
Copyright ©2009 Searchles, Inc. All Rights Reserved
